Herpes simplex glycoprotein vaccine
Latest Information Update: 03 May 2007
At a glance
- Originator Johns Hopkins Medical Institutions; Nonindustrial source; University of Maryland School of Medicine
- Developer Johns Hopkins Medical Institutions; Nonindustrial source; University of Maryland School of Medicine; University of Tennessee
- Class Synthetic vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections